Current position:Home >Product >
Morpholine, 4-(8-hydroxy-3,7-dimethyl-1-oxo-2,6-octadienyl)-, (E,E)-
Morpholine, 4-(8-hydroxy-3,7-dimethyl-1-oxo-2,6-octadienyl)-, (E,E)-(65811-50-9)
- Name: Morpholine, 4-(8-hydroxy-3,7-dimethyl-1-oxo-2,6-octadienyl)-, (E,E)-
- Synonyms:
- Molecular Formula:C14H23NO3
- Molecular Weight:
- CAS Registry Number:65811-50-9
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 65811-23-6/Bicyclo[2.2.1]hept-2-ene-2-carbonitrile, 3-phenyl-
- 65811-26-9/Benzene, [2-(2,2,2-trifluoroethoxy)cyclohexyl]-, cis-
- 65811-27-0/Benzene, [2-(2,2,2-trifluoroethoxy)cyclohexyl]-, trans-
- 65811-28-1/Bicyclo[2.2.1]heptane, 2-phenyl-3-(2,2,2-trifluoroethoxy)-, (2-endo,3-exo)-
- 65811-29-2/Octane, 1,1',1''-[1,2,3-propanetriyltris(oxy)]tris-
- 65811-31-6/Propanediamide, 2-(3-methyl-2-butenyl)-N,N'-diphenyl-2-(phenylamino)-
- 65811-34-9/Propanediamide, 2-(3-methyl-2-butenyl)-N,N'-diphenyl-
- 65811-35-0/Propanediamide, 2-methoxy-2-(3-methyl-2-butenyl)-N,N'-diphenyl-
- 65811-38-3/Hexanamide, 2-[(2,4-dinitrophenyl)hydrazono]-N-phenyl-
- 65811-40-7/2,6,10,14-Hexadecatetraenoic acid, 7-(hydroxymethyl)-3,11,15-trimethyl-, (E,E,E)-
- 65811-41-8/2,6,10,14-Hexadecatetraenoic acid, 7-(hydroxymethyl)-3,11,15-trimethyl-, (Z,Z,E)-
- 65811-42-9/2,6,10,14-Hexadecatetraenoic acid, 7-(hydroxymethyl)-3,11,15-trimethyl-, (Z,E,E)-
- 65811-43-0/5,9-Undecadienoic acid, 2-(6-hydroxy-4-methyl-4-hexenylidene)-6,10-dimethyl-, ethyl ester, (E,E,E)-
- 65811-44-1/5,9-Undecadienoic acid, 2-(6-hydroxy-4-methyl-4-hexenylidene)-6,10-dimethyl-, (Z,E,E)-
- 65811-45-2/5,9-Undecadienoic acid, 2-(6-hydroxy-4-methyl-4-hexenylidene)-6,10-dimethyl-, (E,E,E)-
- 65811-46-3/2,6,10,14-Hexadecatetraenamide, 7-(hydroxymethyl)-3,11,15-trimethyl-, (E,Z,E)-
- 65811-47-4/2,6,10,14-Hexadecatetraenamide, 7-(hydroxymethyl)-3,11,15-trimethyl-, (E,E,E)-
- 65811-48-5/2,6-Octadienamide, N,N-diethyl-8-hydroxy-3,7-dimethyl-, (E,E)-
- 65811-49-6/2,6-Octadienamide, N,N-diethyl-8-hydroxy-3,7-dimethyl-, (Z,E)-
- 65811-50-9/Morpholine, 4-(8-hydroxy-3,7-dimethyl-1-oxo-2,6-octadienyl)-, (E,E)-
- 65811-51-0/Morpholine, 4-(8-hydroxy-3,7-dimethyl-1-oxo-2,6-octadienyl)-, (Z,E)-
- 65811-54-3/2,6,10,14-Hexadecatetraenamide, 7-(hydroxymethyl)-3,11,15-trimethyl-N-(phenylmethyl)-, (E,Z,E)-
- 65811-55-4/2,6,10,14-Hexadecatetraenamide, 7-(hydroxymethyl)-3,11,15-trimethyl-N-(phenylmethyl)-, (E,E,E)-
- 65811-56-5/2,6,10,14-Hexadecatetraenamide, N-ethyl-7-(hydroxymethyl)-3,11,15-trimethyl-, (E,Z,E)-
- 65811-57-6/2,6,10,14-Hexadecatetraenamide, N-ethyl-7-(hydroxymethyl)-3,11,15-trimethyl-, (E,E,E)-
- 65811-58-7/2,6,10,14-Hexadecatetraenamide, N-ethyl-7-(hydroxymethyl)-3,11,15-trimethyl-, (Z,Z,E)-
- 65811-59-8/2,6,10,14-Hexadecatetraenamide, N-ethyl-7-(hydroxymethyl)-3,11,15-trimethyl-, (Z,E,E)-
- 65811-60-1/2,6,10,14-Hexadecatetraenamide, 7-(hydroxymethyl)-3,11,15-trimethyl-N-[2-(1-pyrrolidinyl)ethyl]-, (E,Z,E)-
- 65811-61-2/2,6,10,14-Hexadecatetraenamide, 7-(hydroxymethyl)-3,11,15-trimethyl-N-[2-(1-pyrrolidinyl)ethyl]-, (E,E,E)-
- 65811-62-3/2,6,10,14-Hexadecatetraenamide, 7-(hydroxymethyl)-3,11,15-trimethyl-N-[2-(1-pyrrolidinyl)ethyl]-, (Z,Z,E)-